Nagpur: After 90-days of hospitalisation, including 70 days on ventilator support, 11-year-old Viraj returned home on January ...

A woman experienced what she described as an "electric shock" sensation when kissing her husband, only to discover that this ...

The Karnataka High Court ruling came in the case of a man diagnosed with Guillain-Barré Syndrome (GBS), who had been in the ...

In a new interview with Vulture, Sufjan Stevens opened up about his health following his 2023 diagnosis with Guillain-Barré ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome ...

The GBS | CIDP Foundation International is making strides to increase awareness of Guillain-Barré Syndrome (GBS), Chronic ...

FDA Meeting for Tanruprubart (formerly ANX005), the First Potential Targeted Therapy for GBS, Scheduled for Second Quarter 2025 Ahead of Planned BLA Submission Open-Label Tanruprubart FORWARD Study De ...

To further our strategic development plan, preparing to initiate the open-label tanruprubart FORWARD study, measuring pharmacokinetics, pharmacodynamics, early efficacy in week 1, and safety in up to ...

The GBS | CIDP Foundation International is commemorating Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy Awareness Month this May by launching a global campaign to raise ...